EUVIMEDEUVIMED entdecken
Open Access

The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67 Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides

Jingli Xu, Fabio Gallazzi, Darrell R Fisher iD, Rene Gonzalez, Yubin Miao iD

Cancer Biotherapy and Radiopharmaceuticals · 2022-02 · 37 (1) · 47-55

DOI: 10.1089/cbr.2021.0273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, online erschienen am 08.02.2022. Verfasst von Jingli Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Melanoma, Experimental, alpha-MSH. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to examine the effect of 4- p -(tolyl)butyric acid as an albumin-binding (ALB) moiety on tumor targeting and biodistribution properties of 67 Ga-labeled albumin binder-conjugated alpha-melanocyte-stimulating hormone peptides. Materials and Methods: DOTA-Lys(ALB)-G/GG/GGG-Nle-CycMSH hex {1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Lys(ALB)-Gly/GlyGly/GlyGlyGly-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-CONH 2 } were synthesized with 4- p -(tolyl)butyric acid serving as an ALB moiety. The melanocortin-1 receptor (MC1R)-binding affinities of the peptides were determined on B16/F10 melanoma cells. The biodistribution of 67 Ga-DOTA-Lys(ALB)-G/GG/GGG-Nle-CycMSH hex was examined on B16/F10 melanoma-bearing C57 mice at 2 h postinjection to select a lead peptide for further evaluation. The melanoma targeting and imaging properties of 67 Ga-DOTA-Lys(ALB)-GGNle-CycMSH hex { 67 Ga-ALB-G2} were determined on B16/F10 melanoma-bearing C57 mice.

Results

The IC 50 value of DOTA-Lys(ALB)-G/GG/GGG-Nle-CycMSH hex {ALB-G1, ALB-G2, ALB-G3} was 0.67 ± 0.07, 0.5 ± 0.09 and 0.51 ± 0.03 nM on B16/F10 cells, respectively. 67 Ga-ALB-G2 was further evaluated as a lead peptide because of its higher tumor uptake (30.25 ± 3.24%ID/g) and lower kidney uptake (7.09 ± 2.22%ID/g) than 67 Ga-ALB-G1 and 67 Ga-ALB-G3 at 2 h postinjection. The B16/F10 melanoma uptake of 67 Ga-ALB-G2 was 15.64 ± 4.55, 30.25 ± 3.24, 26.76 ± 3.23, and 10.71 ± 1.21%ID/g at 0.5, 2, 4, and 24 h postinjection, respectively. The B16/F10 melanoma lesions were clearly visualized by SPECT/CT using 67 Ga-ALB-G2 as an imaging probe at 2 h postinjection.

Conclusions

The introduction of 4- p -(tolyl)butyric acid as an ALB moiety increased the blood retention, and resulted in higher tumor/kidney ratio of 67 Ga-ALB-G2 as compared with its counterpart without an albumin binder. However, the resulting high uptake of 67 Ga-ALB-G2 in blood and liver need to be further reduced to facilitate its therapeutic application when replacing 67 Ga with therapeutic radionuclides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Melanoma, Experimentalalpha-MSHAlbuminsAnimalsCell Line, TumorLactamsMiceMice, Inbred C57BLRadiopharmaceuticalsTissue Distribution

Stichwörter der Autor:innen

albumin-binding moietyalpha-melanocyte-stimulating hormonemelanocortin-1 receptormelanoma targeting

Substanzen

AlbuminsLactamsRadiopharmaceuticalsalpha-MSH

Autor:innen und Institutionen

  • Department of Radiology, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
  • Department of Chemistry and Molecular Interactions Core, University of Missouri, Columbia, Missouri, USA.
  • Department of Pharmaceutical Sciences, Washington State University, Richland, Washington, USA.
  • Department of Medical Oncology, University of Colorado Denver, Aurora, Colorado, USA.

ORCID-Profile: Darrell R Fisher, Yubin Miao

Förderung

  • NCI NIH HHS

Zitieren

APA

Xu, J., Gallazzi, F., Fisher, D. R., Gonzalez, R., & Miao, Y. (2022). The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67 Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides. Cancer Biotherapy and Radiopharmaceuticals, 37(1), 47-55. https://doi.org/10.1089/cbr.2021.0273

Vancouver

Xu J, Gallazzi F, Fisher DR, Gonzalez R, Miao Y. The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67 Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(1):47-55. doi:10.1089/cbr.2021.0273

BibTeX
@article{Xu2022,
  author = {Xu, Jingli and Gallazzi, Fabio and Fisher, Darrell R and Gonzalez, Rene and Miao, Yubin},
  title = {The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67 Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2022},
  volume = {37},
  number = {1},
  pages = {47--55},
  doi = {10.1089/cbr.2021.0273}
}
Kostenlos starten →